Abivax S.A. (ABVX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ABVX Abivax S.A.

Watchlist

8.700
-0.160-1.81%

Close Nov 21 16:00 ET

8.700
0.0000.00%

Post 16:00 ET

547.42MMarket Cap-2421P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Abivax Announced At-The-Market Program To Sell ADS For Up To $150M Over 3 Years
BenzingaNov 19 16:52 ET
Abivax Reports Liqyuduty Position
Seeking AlphaNov 15 07:23 ET
Express News | Abivax Q3 Total Principal Debt Outstanding €106.3M Down From €108.4M YoY
BenzingaNov 14 17:12 ET
Abivax Presents Third Quarter 2024 Key Financial Information
GlobeNewswireNov 14 16:01 ET
Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax
GlobeNewswireNov 13 16:01 ET
Earnings Preview: Abivax S.A. to Report Financial Results Pre-market on November 07
Moomoo NewsNov 3 13:17 ET

Comments

This_Guy

Sep 25 15:05

$Abivax S.A. (ABVX.US)$
Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model
Abivax has announced initial preclinical combination data of obefazimod and etrasimod in an inflammatory bowel disease (IBD) mouse model. The company is conducting studies with multiple oral and injectable therapies, with additional data expected in Q4 2024. The p...

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

ABVX Abivax S.A.

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target